Freudenhammer, M;
Karampatsas, K;
Le Doare, K;
Lander, F;
Armann, J;
Acero Moreno, D;
Boyle, M;
Buxmann, H;
Campbell, R;
Chalker, V;
et al.
Freudenhammer, M; Karampatsas, K; Le Doare, K; Lander, F; Armann, J; Acero Moreno, D; Boyle, M; Buxmann, H; Campbell, R; Chalker, V; Cunney, R; Doherty, L; Davies, E; Efstratiou, A; Elling, R; Endmann, M; Essers, J; Hentschel, R; Jones, CE; Kallsen, S; Kapatai, G; Krüger, M; Ladhani, S; Lamagni, T; Lindsay, D; Meehan, M; O'Sullivan, CP; Patel, D; Reynolds, AJ; Roll, C; Schulzke, S; Smith, A; Stein, A; von der Wense, A; Voss, E; Wieg, C; Härtel, C; Heath, PT; Henneke, P
(2021)
Invasive Group B Streptococcus Disease With Recurrence and in Multiples: Towards a Better Understanding of GBS Late-Onset Sepsis.
Front Immunol, 12.
p. 617925.
ISSN 1664-3224
https://doi.org/10.3389/fimmu.2021.617925
SGUL Authors: Le Doare, Kirsty Karampatsas, Konstantinos
|
PDF
Published Version
Available under License Creative Commons Attribution. Download (14MB) | Preview |
|
Microsoft Word (.docx) (Supplementary material 1)
Published Version
Available under License Creative Commons Attribution. Download (54kB) |
||
|
Image (TIFF) (Supplementary material 2)
Published Version
Available under License Creative Commons Attribution. Download (138kB) | Preview |
Abstract
Group B Streptococcus (GBS) is a common intestinal colonizer during the neonatal period, but also may cause late-onset sepsis or meningitis in up to 0.5% of otherwise healthy colonized infants after day 3 of life. Transmission routes and risk factors of this late-onset form of invasive GBS disease (iGBS) are not fully understood. Cases of iGBS with recurrence (n=25) and those occurring in parallel in twins/triplets (n=32) from the UK and Ireland (national surveillance study 2014/15) and from Germany and Switzerland (retrospective case collection) were analyzed to unravel shared (in affected multiples) or fixed (in recurrent disease) risk factors for GBS disease. The risk of iGBS among infants from multiple births was high (17%), if one infant had already developed GBS disease. The interval of onset of iGBS between siblings was 4.5 days and in recurrent cases 12.5 days. Disturbances of the individual microbiome, including persistence of infectious foci are suggested e.g. by high usage of perinatal antibiotics in mothers of affected multiples, and by the association of an increased risk of recurrence with a short term of antibiotics [aOR 4.2 (1.3-14.2), P=0.02]. Identical GBS serotypes in both recurrent infections and concurrently infected multiples might indicate a failed microbiome integration of GBS strains that are generally regarded as commensals in healthy infants. The dynamics of recurrent GBS infections or concurrent infections in multiples suggest individual patterns of exposure and fluctuations in host immunity, causing failure of natural niche occupation.
Item Type: | Article | |||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Additional Information: | Copyright © 2021 Freudenhammer, Karampatsas, Le Doare, Lander, Armann, Acero Moreno, Boyle, Buxmann, Campbell, Chalker, Cunney, Doherty, Davies, Efstratiou, Elling, Endmann, Essers, Hentschel, Jones, Kallsen, Kapatai, Krüger, Ladhani, Lamagni, Lindsay, Meehan, O’Sullivan, Patel, Reynolds, Roll, Schulzke, Smith, Stein, von der Wense, Voss, Wieg, Härtel, Heath and Henneke. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. | |||||||||||||||||||||||||||
Keywords: | group B Streptococcus, late-onset sepsis, microbiome, multiples, recurrence | |||||||||||||||||||||||||||
SGUL Research Institute / Research Centre: | Academic Structure > Infection and Immunity Research Institute (INII) | |||||||||||||||||||||||||||
Journal or Publication Title: | Front Immunol | |||||||||||||||||||||||||||
ISSN: | 1664-3224 | |||||||||||||||||||||||||||
Language: | eng | |||||||||||||||||||||||||||
Dates: |
|
|||||||||||||||||||||||||||
Publisher License: | Creative Commons: Attribution 4.0 | |||||||||||||||||||||||||||
Projects: |
|
|||||||||||||||||||||||||||
PubMed ID: | 34149682 | |||||||||||||||||||||||||||
Go to PubMed abstract | ||||||||||||||||||||||||||||
URI: | https://openaccess.sgul.ac.uk/id/eprint/113379 | |||||||||||||||||||||||||||
Publisher's version: | https://doi.org/10.3389/fimmu.2021.617925 |
Statistics
Actions (login required)
Edit Item |